Back to search

Article

“Drug holiday” in DRONJ (Denosumab Related Osteonecrosis of the Jaws) patients : real benefit in surgical or non surgical therapeutic approach ?

2021-04-02

Abstract excerpt

One of the most frequent monoclonal antibodies linked to MRONJ is Denosumab. In our study, attention was focused on different therapeutic approaches considering patients treated only with Denosumab or in combination with other drugs associated with the genesis of ONJ. We considered two different clinical approaches: sites treated without surgery; sites treated with traditional surgery or Er:YAG laser (2940nm, 250m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ed1fcbc-2880-5405-a014-f2ec65919f2a
DOI
10.32388/t8q4z9
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
“Drug holiday” in DRONJ (Denosumab Related Osteonecrosis of the Jaws) patients : real benefit in surgical or non surgical therapeutic approach ?DOI 10.32388/t8q4z9
Denosumab-Related Osteonecrosis of the Jaw: a five year monocentric retrospective study of Ancona General HospitalSemantic proximity
Effects of Preoperative Drug Holiday On Sequester Separation and Treatment Outcome in Cancer Patients With Medication-Related Osteonecrosis of The JawSemantic proximity
Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumabSemantic proximity
Surgical treatment of MRONJ in oncology and non-oncology patients: a retrospective studySemantic proximity
The awareness and perceptions of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional surveySemantic proximity
SURGICAL TREATMENT OF MEDICATION-RELATED OSTEONECROSIS OF THE JAW: TECHNICAL REPORT AND PROGNOSIS ASSESSMENTSemantic proximity
Difference in outcomes in surgical treatment of stage II-II MRONJ in oncological and non-oncological patients.Semantic proximity
Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.Semantic proximity
Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.Semantic proximity
Prevalence of late stage in 507 Medication-related osteonecrosis of the jaws (MRONJ) sites: comparison between cancer and osteometabolic patientsSemantic proximity
The Trend of Dental Check-Up And Incidence of Dental Complications Following The Use of Bone Modifying Agents In Patients With Metastatic Breast And Prostate Cancer: Analysis of Data From The Korean National Health Insurance ServiceSemantic proximity
Surgical and conservative treatment outcomes of medication-related osteonecrosis of the jaw in relation to tori: A retrospective studySemantic proximity
Select a neighboring publication to make it the new centre.